Vertex Pharmaceuticals

Vertex Pharmaceuticals Inc., Boston, MA 02210

Public
Healthcare & Pharmaceuticals - Biotechnology
over $1B
over 10K
(617) 341-6100


Vertex Pharmaceuticals Incorporated is engaged in the business of discovering, developing, manufacturing and commercializing medicines for serious diseases. The Company operates in pharmaceuticals segment. Its business is focused on developing and commercializing therapies for the treatment of cystic fibrosis (CF) and advancing its research and development programs in other indications. Its marketed medicines are ORKAMBI and KALYDECO, which are approved to treat patients with CF having specific mutations in their CF transmembrane conductance regulator (CFTR) gene. It has multiple development programs in the field of CF, including VX-661, VX-371, and VX-152 and VX-440. It is engaged in various other research and mid- and early-stage development programs, such as programs in the areas of onc... (Source: SEC reports)


Competitor - 1/8
Which company is more competitive with Vertex Pharmaceuticals?




303 Contacts at this company
Kelly Prescott
Director, National Accounts Team
Andrew Lange
Director, Medicinal Chemistry Operations ...
Steve Kaupp
Global Strategic Sourcing Manager, IT and
Kristin Stephan
Director, Medical Writing
Geny Doss
QC Manager
Emanuele Perola
Research Fellow II
Mike Arnost
Scientist II
Christopher Chin, PharmD
Director Global Medical ...

Sep 11, 2018 18:54:16
BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that management [...]

Sep 11, 2018 17:30:54
BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that management [...]

Sep 10, 2018 17:30:38
BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Katharine Jensen has been appointed Head of [...]

Sep 10, 2018 16:32:58
BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Katharine Jensen has been appointed Head of [...]

Sep 6, 2018 19:18:42
BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that enrollment [...]

Get Started Today : Sign up in 20 seconds
Search with 20+ criteria.
Export results in seconds.
Bad emails?
No worry, we give two extras for every bad email.